Advances in Trop-2 targeted antibody-drug conjugates for breast cancer: Mechanisms, clinical applications, and future directions
Last Updated: Friday, July 17, 2026
A recent review looks at advancements in Trop-2-targeted antibody-drug conjugates. It focuses on new research directions as well as potential strategies to improve treatment outcomes and patient quality of life.